Not Yet Recruiting
An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy
NCT07631871
- Conditions
- Adnexal Diseases, CERVICAL NEOPLASMS, Carcinoma, +38 more
- Locations
-
Not specified